ketoconazole has been researched along with Rhinosporidiosis in 4 studies
1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.
Rhinosporidiosis: Chronic, localized granulomatous infection of mucocutaneous tissues, especially the NOSE, and characterized by HYPERPLASIA and the development of POLYPS. It is found in humans and other animals and is caused by the mesomycetozoean organism RHINOSPORIDIUM SEEBERI.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Dapsone has been frequently used in treating disseminated disease in immunocompetent individuals." | 5.39 | Novel multidrug therapy for disseminated rhinosporidiosis, refractory to dapsone – case report. ( Agarwala, M; Chopra, M; Deodhar, D; Dincy, P; George, L; Maheswaran, S; Pulimood, S; Rupali, P; Thomas, M, 2013) |
| "Dapsone has been frequently used in treating disseminated disease in immunocompetent individuals." | 1.39 | Novel multidrug therapy for disseminated rhinosporidiosis, refractory to dapsone – case report. ( Agarwala, M; Chopra, M; Deodhar, D; Dincy, P; George, L; Maheswaran, S; Pulimood, S; Rupali, P; Thomas, M, 2013) |
| "In order to measure the frequency of rhinosporidiosis in Africa, anatomo-pathological examination of all O." | 1.31 | [Intranasal rhinosporidiosis: presentation of the 1st case seen in the Congo]. ( Ondzotto, G, 2002) |
| "Being endemic in India and Sri Lanka, rhinosporidiosis is not much known in Africa where only few cases have been reported for the last 20 years." | 1.28 | [Endonasal rhinosporidiosis (apropos of 2 cases observed in Gabon)]. ( Conessa, C; Debrie, JC; Maurice, N; Salgas, P; Tomasi, M; Verdalle, P, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| George, L | 1 |
| Dincy, P | 1 |
| Chopra, M | 1 |
| Agarwala, M | 1 |
| Maheswaran, S | 1 |
| Deodhar, D | 1 |
| Rupali, P | 1 |
| Thomas, M | 1 |
| Pulimood, S | 1 |
| Miller, RI | 1 |
| Baylis, R | 1 |
| Ondzotto, G | 1 |
| Debrie, JC | 1 |
| Salgas, P | 1 |
| Verdalle, P | 1 |
| Conessa, C | 1 |
| Tomasi, M | 1 |
| Maurice, N | 1 |
4 other studies available for ketoconazole and Rhinosporidiosis
| Article | Year |
|---|---|
Novel multidrug therapy for disseminated rhinosporidiosis, refractory to dapsone – case report.
Topics: Anti-Infective Agents; Cycloserine; Dapsone; Drug Therapy, Combination; Humans; Ketoconazole; Male; | 2013 |
Rhinosporidiosis in a dog native to the UK.
Topics: Animals; Antifungal Agents; Dog Diseases; Dogs; Ketoconazole; Male; Nasal Mucosa; Rhinosporidiosis; | 2009 |
[Intranasal rhinosporidiosis: presentation of the 1st case seen in the Congo].
Topics: Adult; Antifungal Agents; Biopsy; Congo; Diagnosis, Differential; Electrocoagulation; Follow-Up Stud | 2002 |
[Endonasal rhinosporidiosis (apropos of 2 cases observed in Gabon)].
Topics: Biopsy; Child; Combined Modality Therapy; Female; Humans; Ketoconazole; Nasal Cavity; Nasal Septum; | 1990 |